The Ultimate Fighting Championship signed a deal with the United States Anti-Doping Agency (USADA) to help clean the sport of mixed martial arts and rid the octagon of performance enhancing drugs. Fighters who are on the active UFC roster are subjected to random drug tests and Tom Lawlor is one of the most recent fighters to receive a ban.
Lawlor was recently flagged by USADA for testing positive for ostarine stemming from an out of competition drug test conducted on October 10, 2016. The suspension starts the date of the failed test, so Lawlor will be able to return to action in October of 2018. USADA released a full statement which you can read below:
“USADA announced today that UFC® athlete, Tom Lawlor, of Las Vegas, Nev., accepted a two-year sanction after testing positive for a prohibited substance.
Lawlor, 33, tested positive for ostarine following an out-of-competition urine test conducted on October 10, 2016. Ostarine is a prohibited substance in the category of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.
Ostarine, also known as MK-2866 and Enobosarm, is a non-FDA approved selective androgen receptor modulator (SARM) which is illegally sold in the United States and globally as a performance-enhancing substance. Ostarine is not currently available as a prescription medication in any country, and its unauthorized use may carry serious side effects. Nonetheless, ostarine has been found as a declared and undeclared ingredient in many dietary supplements sold in the United States, which has prompted the U. S. Food and Drug Administration (FDA) to issue warning letters to specific dietary supplement manufacturers stating that ostarine is an unapproved new drug and that selling the drug is in violation of the Federal Food, Drug, and Cosmetic Act (FDCA).
Lawlor’s two-year period of ineligibility began on October 10, 2016, the date his positive sample was collected.”
